Side-by-side comparison of AI visibility scores, market position, and capabilities
Orrville OH consumer foods (NYSE: SJM) at $8.7B FY2025 revenue (+7%); Uncrustables fastest-growing brand, Hostess ($5.6B acquisition 2023) integration challenge, Jif/Folgers/Café Bustelo portfolio competing with Kraft Heinz.
The J.M. Smucker Company is an Orrville, Ohio-based consumer packaged goods company — publicly traded on the New York Stock Exchange (NYSE: SJM) as an S&P 500 Consumer Staples component — manufacturing and marketing a portfolio of leading food and beverage brands across coffee, peanut butter, fruit spreads, frozen sandwiches, and sweet baked goods through approximately 8,500 employees, with fiscal year 2025 net sales of $8.7 billion (+7% year-over-year). J.M. Smucker's brand portfolio spans three segments: U.S. Retail Pet Foods (Milk-Bone dog treats, Meow Mix, 9Lives, Kibbles 'n Bits), U.S. Retail Coffee (Folgers, Café Bustelo, Dunkin' retail coffee), and U.S. Retail Consumer Foods (Smucker's jams and jellies, Jif peanut butter, Uncrustables frozen sandwiches, and the Hostess sweet baked snacks portfolio). The Hostess acquisition (November 2023, $5.6 billion) made Smucker the owner of America's most iconic sweet baked goods brands — Twinkies, Donettes, Ding Dongs, Ho Hos, and Hostess CupCakes — while presenting integration challenges as the sweet baked snacks category faces shelf-stable competition from private label and shifting consumer preferences. CEO Mark Smucker (grandson of founder Jerome Monroe Smucker who founded the company in 1897) leads the company's brand portfolio management strategy, with Uncrustables (frozen peanut butter and jelly sandwiches, the fastest-growing Smucker brand) and Café Bustelo (Spanish-language espresso-style coffee, growing with US Hispanic demographics) as the primary growth drivers.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.